N Das

Summary

Publications

  1. ncbi Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE
    Nibhriti Das
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    Adv Exp Med Biol 735:55-81. 2013
  2. pmc APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among northern Indians
    S Chhabra
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India
    Dis Markers 21:169-74. 2005
  3. ncbi Membrane-Bound Complement Regulatory Proteins as Biomarkers and Potential Therapeutic Targets for SLE
    Nibhriti Das
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India
    Adv Exp Med Biol 734:55-81. 2013
  4. ncbi Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD
    S Chhabra
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
    Mol Cell Biochem 259:59-66. 2004
  5. ncbi Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies
    K R Raju
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi
    Asian Pac J Allergy Immunol 19:23-7. 2001
  6. ncbi Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis
    M Arora
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi
    Lupus 9:127-31. 2000
  7. ncbi Modulation of urinary CR1 in systemic lupus erythematosus
    B Sivasankar
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    Lupus 13:228-33. 2004
  8. ncbi Validation of an ELISA for the quantitation of human complement receptor 1
    B Sivasankar
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi
    J Immunoassay Immunochem 22:289-97. 2001
  9. ncbi Genetic and structural polymorphism of complement receptor 1 in normal Indian subjects
    M Katyal
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, 110029, New Delhi, India
    Immunol Lett 89:93-8. 2003
  10. ncbi Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study
    K Luthra
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    Clin Genet 62:39-44. 2002

Collaborators

Detail Information

Publications15

  1. ncbi Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE
    Nibhriti Das
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    Adv Exp Med Biol 735:55-81. 2013
    ..Following is a brief appraisal on membrane-bound complement regulatory proteins DAF, MCP, CR1, and CD59 as biomarkers and therapeutic targets for SLE...
  2. pmc APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among northern Indians
    S Chhabra
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India
    Dis Markers 21:169-74. 2005
    ..Our study, first of its kind from India, suggests that 'A' allele may contribute to severity of CAD and low levels of HDL and apoA-I. However, an in depth study with a larger set of sample is necessary...
  3. ncbi Membrane-Bound Complement Regulatory Proteins as Biomarkers and Potential Therapeutic Targets for SLE
    Nibhriti Das
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India
    Adv Exp Med Biol 734:55-81. 2013
    ..Following is a brief appraisal on membrane-bound complement regulatory proteins DAF, MCP, CR1, and CD59 as biomarkers and therapeutic targets for SLE...
  4. ncbi Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD
    S Chhabra
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
    Mol Cell Biochem 259:59-66. 2004
    ..Thus, our study reveals that rare S2 allele may be employed as a susceptibility marker for high TG. However, high TG or S2 allele alone may not contribute to the etiology of CAD...
  5. ncbi Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies
    K R Raju
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi
    Asian Pac J Allergy Immunol 19:23-7. 2001
    ..G-CR1 serves as a useful diagnostic marker for IC mediated diseases while E-CR1 is useful as a prognostic marker to monitor the course of disease after the treatment has initiated...
  6. ncbi Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis
    M Arora
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi
    Lupus 9:127-31. 2000
    ..However, expression of DAF and CD59 was increased on both erythrocytes and glomerulus of DPGN patients, suggesting the generation of a protective response against complement-mediated injury...
  7. ncbi Modulation of urinary CR1 in systemic lupus erythematosus
    B Sivasankar
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    Lupus 13:228-33. 2004
    ..Our findings thus suggest that uCR1 reflects the levels of GCR1 expression, which decline drastically in SLE. Therefore we envisage uCR1 as a potential marker for glomerular involvement in SLE...
  8. ncbi Validation of an ELISA for the quantitation of human complement receptor 1
    B Sivasankar
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi
    J Immunoassay Immunochem 22:289-97. 2001
    ..The samples were checked for loss of sCR1 levels through freeze/thaw cycles at different intervals of time stored at -70 degrees C...
  9. ncbi Genetic and structural polymorphism of complement receptor 1 in normal Indian subjects
    M Katyal
    Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, 110029, New Delhi, India
    Immunol Lett 89:93-8. 2003
    ..Our findings are unique as we found that gene frequencies for structural and quantitative polymorphism in our study subjects were a combination of those found in Caucasian and Oriental populations...
  10. ncbi Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study
    K Luthra
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    Clin Genet 62:39-44. 2002
    ..This study suggests that apo epsilon4 allele, triglycerides, age and hypertension are the predictors for stroke development...
  11. ncbi Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis
    S Das
    Department of Biochemistry, Sir Ganga Ram Hospital, New Delhi, India
    Mol Cell Biochem 285:143-7. 2006
    ..001). This suggests that use of ascorbic acid may have great promise in the prevention of hypercholesterolemia induced atherosclerosis...
  12. doi Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus
    B Biswas
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    Lupus 21:517-25. 2012
    ..A protective role of MCP in response to increased disease burden may be speculated. The follow-up study suggested MCP as a potential disease marker...
  13. pmc Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians
    S Chhabra
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India
    BMC Genet 3:9. 2002
    ..We conducted a study on the relationship between APOC3 SstI polymorphism (S1S1, S1S2 and S2S2 genotypes) and plasma TG levels in a group of 139 male healthy volunteers from Northern India...
  14. pmc Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients
    D Anand
    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    Clin Exp Immunol 176:327-35. 2014
    ..Lower levels of L-CR1 transcript in patients compared to controls, their correlations with the levels of CIC, C3d and DAS28 at different time-points in RA patients suggest CR1 as a potential disease marker for RA. ..